반응 #10507

ord-f6fabe9f122d4790935ad38391ad854e

반응 방정식

C[C@@H]1CCCN1CCc1cc2cc(Br)ccc2[nH]1
5-bromo-2-[2-(2-(R)-methyl-pyrrolidin-1-yl)-ethyl]-1H-indole
O=C([O-])[O-].[Cs+].[Cs+]
Cs2CO3
[Cs+].[F-]
CsF
N#Cc1ccc(B(O)O)cc1
4-cyanophenylboronic acid
c1ccc(-c2ccccc2P(C2CCCCC2)C2CCCCC2)cc1
2-dicyclohexylphosphino(biphenyl)
C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2[nH]1
title compound
수율 44.9%
C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2[nH]1
4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-1H-indol-5-yl}-benzonitrile
수율 44.9%

반응 조건

온도
65°CELSIUS
상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The resulting mixture was purged with nitrogen
  2. 2
    기타The resulting reaction mixture
  3. 3
    기타was consumed
  4. 4
    온도The reaction mixture was cooled to room temperature
  5. 5
    workup.ADDITIONIPAc (20 mL) was added
  6. 6
    기타The organic layer was separated
  7. 7
    농축concentrated
  8. 8
    기타The residue was purified by column chromatography
  9. 9
    세척eluting with heptane/acetone/CH2Cl2/Et3N (600 mL/40 mL/5 mL/2 mL)
  10. 10
    workup.ADDITIONThe fractions containing product
  11. 11
    농축concentrated under reduced pressure

실험 절차

A reaction flask was charged with Cs2CO3 (1.14 g, 3.5 mmol), CsF (0.38 g, 2.5 mmol), 4-cyanophenylboronic acid (425 mg, 2.5 mmol), and H2O (10 mL) followed by a toluene solution (10 mL) of 5-bromo-2-[2-(2-(R)-methyl-pyrrolidin-1-yl)-ethyl]-1H-indole (307 mg, 1.0 mmol). The resulting mixture was purged with nitrogen. To the reaction mixture was then added 2-dicyclohexylphosphino(biphenyl) (35 mg, 0.1 mmol) and Pd2(dba)3 (46 mg, 0.05 mmol). The resulting reaction mixture was then heated to 65° C. overnight under nitrogen after which HPLC indicated that all the 5-bromo-2-[2-(-(R)-methyl-pyrrolidin-1-yl-ethyl]-1H-indole was consumed. The reaction mixture was cooled to room temperature and IPAc (20 mL) was added. The organic layer was separated and concentrated. The residue was purified by column chromatography eluting with heptane/acetone/CH2Cl2/Et3N (600 mL/40 mL/5 mL/2 mL). The fractions containing product were combined and concentrated under reduced pressure to provide the title compound as a semi-solid (148 mg). 1H NMR (400 MHz, CDCl3) δ 10.22 (s, 1H), 7.65–7.74 (m, 5H), 7.40 (d, J=8.5 Hz, 1H), 7.33 (dd, J=1.8, 8.5 Hz, 1H), 6.27 (s, 1H), 3.37–3.42 (m, 1H), 3.21–3.25 (m, 1H), 3.01–3.16 (m, 2H), 2.54–2.62 (m, 2H), 2.33 (q, J=8.78Hz, 1H), 2.04–2.08 (m, 1H), 1.80–1.93 (m, 2H), 1.56–1.63 (m, 1H), 1.21 (d, J=6.2 Hz, 3H). 13C NMR (400 MHz, CDCl3) δ 146.99, 139.96, 135.61, 132.05, 130.30, 128.74, 127.32, 120.02, 119.13, 118.36, 111.13, 109.16, 99.49, 61.25, 53.68, 53.57, 32.92, 26.21, 22.14, 18.98. [M+H]+ at m/z 330.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07094790B2uspto-grants-2006_08